1 We examined the effects of the alpha-amino-3-hydroxy-5-methyl-4-isoxazole
propionic acid (AMPA)/kainate receptor antagonists 6-cyano-7-nitroquinoxali
ne-2,3-dione (CNQX) and 1,2,3,4-tetrahydro-6-nitro-2,3-dioxo-benzol[f]quino
xaline-7-sulphonamide (NBQX), the kainate receptor antagonists gamma-(R-)-g
lutamylaminomethanesulphonic acid (GAMS) and 6,7,8,9-tetrahydro-5-nitro-1H-
benz[g]indole-2,3-dione-3-oxime (NS-102), and the group III metabotropic gl
utamate receptor (mGluR) agonist 2-amino-4-phosphono-S-butanoic acid (L-AP4
) on c-fos-like immunoreactivity (c-fos LI) in trigeminal caudalis (Sp5C),
lateral reticular (LRt), medullary reticular (Md) and solitary tract (Sol)
nuclei, after intracisternal injection of capsaicin in urethane anaesthetiz
ed Sprague-Dawley rats.
2 Few c-fos labelled cells were observed within Sp5C in capsaicin-vehicle t
reated animals. The number of positive c-fos cells increased by 17 fold aft
er intracisternal capsaicin (5 nmol) administration.
3 Pretreatment with CNQX (0.02, 0.1, 0.6, 3 and 15 mg kg(-1)) or NBQX (0.01
, 0.1 and 1 mg kg(-1)), administered intraperitoneally 15 min before capsai
cin, significantly reduced labelled cells within Sp5C by a maximum of 45 an
d 34%, respectively. The number of c-fos LI cells within LRt, Md and Sol wa
s not affected. Pretreatment with L-AP4 (1, 3 and 10 mg kg(-1)) decreased t
he number of Sp5C c-fos LI cells by a maximum of 30%, whereas GAMS (1 and 1
0 mg kg(-1)) and NS-102 (1 and 5 mg kg(-1)) did not show any significant ef
fect.
4 These results suggest that blockade of AMPA receptors, but not kainate re
ceptors, or the activation of group III mGluRs, decrease the response of Sp
5C neurons to trigeminovascular activation. Thus, in addition to NMDA recep
tors, mGluRs and AMPA receptors may modulate cephalic pain and may provide
a potential therapeutic target for antimigraine drugs.